tiprankstipranks
Trending News
More News >
Advertisement

GB:CYBO ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Neutral
8Bullish
6Neutral
8Bearish
Oscillators
Neutral
2Bullish
6Neutral
2Bearish
Moving Averages
Neutral
6Bullish
0Neutral
6Bearish
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) Moving Averages Convergence Divergence (MACD) indicator is -0.24, suggesting VanEck Bionic Engineering UCITS ETF Accum -A- USD is a Buy.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 20-Day exponential moving average is 20.28, making it a Buy.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 50-Day exponential moving average is 20.49, making it a Sell.

VanEck Bionic Engineering UCITS ETF Accum -A- USD (CYBO) Pivot Points

Oct 06, 2025, 07:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.95
19.93
19.95
19.93
19.95
19.93
19.95
Fibonacci
19.93
19.93
19.93
19.93
19.93
19.93
19.93

VanEck Bionic Engineering UCITS ETF Accum -A- USD (CYBO) Moving Averages

Oct 06, 2025, 07:19 PM
Period
Simple
Exponential
MA5
19.90Buy
20.02Buy
MA10
20.00Buy
20.07Buy
MA20
20.38Buy
20.28Buy
MA50
20.64Sell
20.49Sell
MA100
20.59Sell
20.50Sell
MA200
20.50Sell
20.59Sell
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 10-Day exponential moving average is 20.07, making it a Buy.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 100-Day exponential moving average is 20.50, making it a Sell.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 50-day simple moving average is 20.64, creating a Sell signal.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 100-day simple moving average is 20.59, creating a Sell signal.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 200-day simple moving average is 20.50, creating a Sell signal.

VanEck Bionic Engineering UCITS ETF Accum -A- USD (CYBO) Technical Analysis

Oct 06, 2025, 07:19 PM
Name
Value
Action
RSI (14)
50.22
Neutral
STOCH (9,6)
47.48
Neutral
STOCHRSI (14)
40.72
Neutral
MACD (12,26)
-0.24
Buy
ADX (14)
23.24
Neutral
Williams %R
-14.87
Sell
CCI (14)
-3.31
Neutral
ATR (14)
0.18
-
Ultimate Oscillator
48.60
Neutral
ROC
-1.64
Sell
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) Relative Strength Index (RSI) is 50.22, creating a Neutral signal.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) Trend Strength Indicator (ADX) is 23.24, creating a Neutral signal.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) Commodity Channel Index (CCI) is -3.31, creating a Neutral signal.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) Price Rate of Change (ROC) is -1.64, creating a Sell signal.

FAQ

Is CYBO a Buy, Hold, or Sell?
Based on CYBO’s technical indicators, CYBO is a Hold.
    What is CYBO’s RSI (14)?
    CYBO’s RSI (14) is 50.22, which suggests CYBO is a Neutral.
      What is CYBO’s MACD?
      CYBO’s MACD is -0.24, which suggests CYBO is a Buy.
        What is CYBO’s 5-day moving average?
        CYBO’s 5-day moving average is 19.90, which suggests CYBO is a Buy.
          What is CYBO’s 20-day moving average?
          CYBO 20-day moving average is 20.38, which suggests CYBO is a Buy.
            What is CYBO’s 50-day moving average?
            CYBO’s 50-day moving average is 20.64, which suggests CYBO is a Sell.
              What is CYBO’s 200-day moving average?
              CYBO’s 200-day moving average is 20.50, which suggests CYBO is a Sell.
                What is CYBO’s Williams % R (14)?
                CYBO’s Williams % R (14) is -14.87, which suggests CYBO is a Sell.
                  What is CYBO’s CCI (14)?
                  CYBO’s CCI (14) is -3.31, which suggests CYBO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement